Susan H. Alexander is Executive Vice President, Chief Legal Officer, and Corporate Secretary of Biogen. Biogen is a global Fortune 500 global biotechnology company focused on discovering, developing, and marketing therapies for the treatment of neurological disorders and other serious diseases. Ms. Alexander is a member of the executive team responsible for Biogen’s strategic direction and management. She also advises the Biogen Board of Directors and is responsible for the company’s legal and corporate compliance functions.
Prior to joining Biogen, Ms. Alexander served as Senior Vice President, General Counsel and Corporate Secretary of PAREXEL International, a global provider of services to pharmaceutical, biotech and medical device companies, as General Counsel of IONA Technologies, an international integration software solution provider, and as Counsel to Cabot Corporation, a global specialty chemical company. Ms. Alexander was also previously a partner in the law firms of Hinckley, Allen & Snyder and Fine & Ambrogne.
Ms. Alexander serves on the Executive Committee and as a Governing Trustee of the Dana Farber Cancer Institute and has previously served on the Boards of Invacare Corporation (NYSE) and Yumanity Therapeutics. She has also served on the Business Leadership Council of Wellesley College, the Boston University Law School Alumni Executive Council, the Board of Directors of the New England Legal Foundation, She also previously served as Chair of the Middlesex Community College Foundation, Trustee of the Episcopal Divinity School, Secretary of the Association of Clinical Research Organizations, and as a Director of the Cabot Corporation Foundation. Ms. Alexander has received several awards for her work in the business, legal and nonprofit sectors.
Ms. Alexander received her J.D. degree from Boston University School of Law and her B.A. degree from Wellesley College.